Appointment booking for Dr. Mauro Leyba Jr, MD is currently not available.Dr. Mauro Leyba Jr, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Mauro Leyba Jr, MD (he/him) is a Rheumatologist in Fresno, CA with over 18 years of experience. What is your opinion of Dr. Mauro Leyba Jr, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mauro Leyba Jr, MD has received over $8,790 which includes payments from the following companies:
$1,807.25 from Amgen Inc.
$1,079.34 from Pfizer Inc.
$916.72 from Janssen Biotech, Inc.
$795.42 from Novartis Pharmaceuticals Corporation
$629.00 from Horizon Pharma plc
$610.77 from AbbVie, Inc.
$475.51 from Celgene Corporation
$458.45 from GlaxoSmithKline, LLC.
$356.42 from Genentech USA, Inc.
$268.64 from E.R. Squibb & Sons, L.L.C.
$228.06 from GENZYME CORPORATION
$149.97 from MEDAC PHARMA, INC.
$142.23 from Medtronic USA, Inc.
$128.08 from Mallinckrodt LLC
$126.09 from Takeda Pharmaceuticals America, Inc.
$113.76 from Antares Pharma, Inc.
$86.77 from Mallinckrodt Enterprises LLC
$69.64 from Iroko Pharmaceuticals, LLC
$63.19 from UCB, Inc.
$57.36 from LILLY USA, LLC
Payments received by Dr. Mauro Leyba Jr, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!